BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23224145)

  • 1. MicroRNA-30c targets cytoskeleton genes involved in breast cancer cell invasion.
    Bockhorn J; Yee K; Chang YF; Prat A; Huo D; Nwachukwu C; Dalton R; Huang S; Swanson KE; Perou CM; Olopade OI; Clarke MF; Greene GL; Liu H
    Breast Cancer Res Treat; 2013 Jan; 137(2):373-82. PubMed ID: 23224145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11.
    Bockhorn J; Dalton R; Nwachukwu C; Huang S; Prat A; Yee K; Chang YF; Huo D; Wen Y; Swanson KE; Qiu T; Lu J; Park SY; Dolan ME; Perou CM; Olopade OI; Clarke MF; Greene GL; Liu H
    Nat Commun; 2013; 4():1393. PubMed ID: 23340433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-206 Inhibits Stemness and Metastasis of Breast Cancer by Targeting MKL1/IL11 Pathway.
    Samaeekia R; Adorno-Cruz V; Bockhorn J; Chang YF; Huang S; Prat A; Ha N; Kibria G; Huo D; Zheng H; Dalton R; Wang Y; Moskalenko GY; Liu H
    Clin Cancer Res; 2017 Feb; 23(4):1091-1103. PubMed ID: 27435395
    [No Abstract]   [Full Text] [Related]  

  • 4. MicroRNA-30c inhibits pancreatic cancer cell proliferation by targeting twinfilin 1 and indicates a poor prognosis.
    Sun LL; Cheng M; Xu XD
    World J Gastroenterol; 2019 Nov; 25(42):6311-6321. PubMed ID: 31754292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer.
    Cheng CW; Wang HW; Chang CW; Chu HW; Chen CY; Yu JC; Chao JI; Liu HF; Ding SL; Shen CY
    Breast Cancer Res Treat; 2012 Aug; 134(3):1081-93. PubMed ID: 22476851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-7 inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via targeting FAK expression.
    Kong X; Li G; Yuan Y; He Y; Wu X; Zhang W; Wu Z; Chen T; Wu W; Lobie PE; Zhu T
    PLoS One; 2012; 7(8):e41523. PubMed ID: 22876288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifunctional Liposomes Enable Active Targeting and Twinfilin 1 Silencing to Reverse Paclitaxel Resistance in Brain Metastatic Breast Cancer.
    Du J; Shao Y; Hu Y; Chen Y; Cang J; Chen X; Pei W; Miao F; Shen Y; Muddassir M; Zhang Y; Zhang J; Teng G
    ACS Appl Mater Interfaces; 2021 May; 13(20):23396-23409. PubMed ID: 33982563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TWF1 induces autophagy and accelerates malignant phenotype in lung adenocarcinoma via inhibiting the cAMP signaling pathway.
    Wang Y; Zuo R; Huo G; Han Z; He Y; Luo Y; Chen L; Li G; Cui J; Zhu F; Yue P; Yuan D; Sun Y; Li Z; Chen P; Guo H
    FASEB J; 2023 Jul; 37(7):e23051. PubMed ID: 37358822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pracinostat (SB939), a histone deacetylase inhibitor, suppresses breast cancer metastasis and growth by inactivating the IL-6/STAT3 signalling pathways.
    Chen J; Li N; Liu B; Ling J; Yang W; Pang X; Li T
    Life Sci; 2020 May; 248():117469. PubMed ID: 32109485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-486-5p improves nonsmall-cell lung cancer chemotherapy sensitivity and inhibits epithelial-mesenchymal transition by targeting twinfilin actin binding protein 1.
    Jin X; Pang W; Zhang Q; Huang H
    J Int Med Res; 2019 Aug; 47(8):3745-3756. PubMed ID: 31117868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.
    Su CM; Lee WH; Wu AT; Lin YK; Wang LS; Wu CH; Yeh CT
    J Nutr Biochem; 2015 Jun; 26(6):675-85. PubMed ID: 25792283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splicing program of human MENA produces a previously undescribed isoform associated with invasive, mesenchymal-like breast tumors.
    Di Modugno F; Iapicca P; Boudreau A; Mottolese M; Terrenato I; Perracchio L; Carstens RP; Santoni A; Bissell MJ; Nisticò P
    Proc Natl Acad Sci U S A; 2012 Nov; 109(47):19280-5. PubMed ID: 23129656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of MicroRNAs (MiRs) 203, 887, 3619 and 182 Prevents Vimentin-triggered, Phospholipase D (PLD)-mediated Cancer Cell Invasion.
    Fite K; Gomez-Cambronero J
    J Biol Chem; 2016 Jan; 291(2):719-30. PubMed ID: 26567912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of microRNA-1 derepresses the cytoskeleton regulatory protein twinfilin-1 to provoke cardiac hypertrophy.
    Li Q; Song XW; Zou J; Wang GK; Kremneva E; Li XQ; Zhu N; Sun T; Lappalainen P; Yuan WJ; Qin YW; Jing Q
    J Cell Sci; 2010 Jul; 123(Pt 14):2444-52. PubMed ID: 20571053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-590-5p functions as a tumor suppressor in breast cancer conferring inhibitory effects on cell migration, invasion, and epithelial-mesenchymal transition by downregulating the Wnt-β-catenin signaling pathway.
    Gao J; Yu SR; Yuan Y; Zhang LL; Lu JW; Feng JF; Hu SN
    J Cell Physiol; 2019 Feb; 234(2):1827-1841. PubMed ID: 30191949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor suppressive microRNA‑138 contributes to cell migration and invasion through its targeting of vimentin in renal cell carcinoma.
    Yamasaki T; Seki N; Yamada Y; Yoshino H; Hidaka H; Chiyomaru T; Nohata N; Kinoshita T; Nakagawa M; Enokida H
    Int J Oncol; 2012 Sep; 41(3):805-17. PubMed ID: 22766839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated expression of Twinfilin-1 is correlated with inferior prognosis of lung adenocarcinoma.
    Kaishang Z; Xue P; Shaozhong Z; Yingying F; Yan Z; Chanjun S; Zhenzhen L; Xiangnan L
    Life Sci; 2018 Dec; 215():159-169. PubMed ID: 30391462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of α-tubulin, detyrosinated α-tubulin, and vimentin in CTCs: identification of the interaction between CTCs and blood cells through cytoskeletal elements.
    Kallergi G; Aggouraki D; Zacharopoulou N; Stournaras C; Georgoulias V; Martin SS
    Breast Cancer Res; 2018 Jul; 20(1):67. PubMed ID: 29976237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monospecific antibody targeting of CDH11 inhibits epithelial-to-mesenchymal transition and represses cancer stem cell-like phenotype by up-regulating miR-335 in metastatic breast cancer, in vitro and in vivo.
    Chen JH; Huang WC; Bamodu OA; Chang PM; Chao TY; Huang TH
    BMC Cancer; 2019 Jun; 19(1):634. PubMed ID: 31248373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion.
    Bourguignon LY; Wong G; Earle C; Krueger K; Spevak CC
    J Biol Chem; 2010 Nov; 285(47):36721-35. PubMed ID: 20843787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.